Segantii Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Segantii Capital Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-370,955	Closed	-$3.09M	–	68
2017 Q2	$3.09M	Buy	370,955 +245,955	+197%	+$2M	0.74%	21
2017 Q1	$1M	Sell	125,000 -685,005	-85%	-$5.92M	0.17%	61
2016 Q4	$7.3M	Sell	810,005 -311,375	-28%	-$2.9M	2.01%	12
2016 Q3	$10.5M	Buy	1,121,380 +928,520	+481%	+$8.86M	2.84%	6
2016 Q2	$1.93M	Buy	+192,860	New	+$1.77M	2.12%	9
2016 Q1	–	Sell	-996,365	Closed	-$9.36M	–	195
2015 Q4	$9.36M	Buy	+996,365	New	+$10.9M	2.27%	8
2014 Q3	–	Sell	-1,408,380	Closed	-$12.3M	–	21
2014 Q2	$12.3M	Buy	+1,408,380	New	+$11.8M	4.71%	5

Other funds holding RDY

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Segantii Capital Management's RDY Position: Q3 2017 in Review

Segantii Capital Management sold out of Dr. Reddy's Laboratories (RDY) in Q3 2017, closing a stake of 370,955 shares — an estimated $3.09M sold.

Segantii Capital Management first reported a position in RDY in Q2 2014 and held it in 7 quarters. The position peaked at $12.3M in Q2 2014. 118 funds tracked by Wall St. Rank hold RDY as of Q3 2017.

Segantii Capital Management reported no remaining Dr. Reddy's Laboratories position as of Q3 2017 after selling out during the quarter.
Segantii Capital Management sold 370,955 Dr. Reddy's Laboratories shares in Q3 2017, an estimated $3.09M.
Segantii Capital Management first reported a position in Dr. Reddy's Laboratories in Q2 2014 and held it in 7 quarters.
Segantii Capital Management's Dr. Reddy's Laboratories position peaked at $12.3M in Q2 2014.
118 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2017.

Based on Segantii Capital Management's 13F filing for Q3 2017, filed 3 Nov 2017.